Bioelectronics Corp (BIEL)

[madp]

NEWS!!!!!just got an email from E&E

BioElectronics Update

June 9, 2012

We are pleased by our meeting today with the FDA. We had the opportunity to collectively address senior management and approximately twenty examiners, consultants and department heads. We addressed the application of the technology to support our menstrual pain medical claim.

Dr. Kenneth Mc Leod, our consulting biophysics, made the technical presentation. Ken is the Director of New York State University's Research Center on Pain at Binghamton. Ken has been a Godsend since the inception of our Company. Our Chairman, Dr Richard Staelin, is a mathematician and statistician, was in attendance to support our clinical data analysis.

We therefore expect a decision soon on our Allay™ Menstrual Pain Therapy product. We have another meeting upcoming with the FDA in July on our RecoveryRX™ surgical product. Our request for over-the-counter classification of the ActiPatch is still under consideration.


BioElectronics